The @ weeks values of TRACP-@b for RhCTLA@-Ig group and infliximab group differed significantly from the baseline values in each group ( P < @ ; P < @ ) , whereas only the value for RhCTLA@-Ig group differed significantly from the @ weeks value for the MTX group ( P < @ ) .